Severe acute respiratory syndrome
MONDO:0005091A viral respiratory infection caused by the SARS coronavirus. It is transmitted through close person-to-person contact. It is manifested with high fever, headache, dry cough and myalgias. It may progress to pneumonia and cause death.
Also known as: SARS, SARS coronavirus caused disease or disorder, SARS coronavirus disease or disorder, SARS coronavirus infectious disease, acute respiratory coronavirus infection
33 clinical trials for this condition and its sub-types, 30 tagged with Severe acute respiratory syndrome itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Can an old malaria drug help fight severe COVID-19?
Disease control CancelledThis Phase 3 trial tests whether hydroxychloroquine, given alone or with azithromycin, can improve outcomes for adults hospitalized with moderate to severe COVID-19 lung disease. Participants receive hydroxychloroquine for 10 days, and some also get azithromycin for 5 days. Resea…
Phase 3 • Sponsor: Apsen Farmaceutica S.A. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Thyroid hormone sprayed into lungs to fight COVID ARDS? trial pulled before start
Disease control CancelledThis study planned to test whether putting a thyroid hormone (T3) directly into the lungs could help people with severe COVID-19 who need a breathing machine. The goal was to reduce fluid in the lungs and shorten time on a ventilator. However, the trial was withdrawn before any p…
Phase 2 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
COVID plasma trial pulled before it even started
Disease control CancelledThis study planned to give blood plasma from recovered COVID-19 patients to people in the ICU with severe COVID-19. The goal was to see if it could help them breathe better and survive. However, the trial was withdrawn before enrolling any participants, so no results are availabl…
Phase 1 • Sponsor: Henry Ford Health System • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Rapid COVID test vs. gold standard: study aimed to see if cheap antigen tests work for contact tracing
Diagnosis CancelledThis study planned to compare a rapid antigen detection test against the standard PCR test for diagnosing COVID-19 in people who were close contacts of infected patients but had no symptoms. The goal was to see if the quick, inexpensive antigen test could reliably identify contag…
Sponsor: Juan Fernando Masa Jiménez • Aim: Diagnosis
Last updated Jun 27, 2026 12:25 UTC
-
Can a mild case of COVID-19 harm your kidneys? urine tests may hold the answer
Knowledge-focused By invitation onlyThe KIDCOV study investigates whether mild or asymptomatic COVID-19 that does not require hospitalization increases the risk of kidney injury. Researchers enroll 2,000 adults who tested positive or negative for COVID-19, balanced by race and ethnicity across California, Michigan,…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
COVID vaccine clot study scrapped before start
Knowledge-focused CancelledThis study aimed to collect medical information from people who developed unusual blood clots within four weeks of receiving a COVID-19 vaccine. The goal was to better understand any possible link between the vaccine and these rare events. However, the study was withdrawn before …
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC